Drugplain

Hysingla ER 40 mg/1

hydrocodone bitartrate · TABLET, EXTENDED RELEASE · Knoa Pharma LLC

No Recall HistoryCurrently in Shortage
Plain English

Hysingla ER is a tablet, extended release containing hydrocodone bitartrate at 40 mg/1, taken oral. Manufactured by Knoa Pharma LLC.

Key Facts

Brand Name
Hysingla ER
Generic Name
hydrocodone bitartrate
NDC Code (Product)
59011-273
Manufacturer
Knoa Pharma LLC
Strength
40 mg/1
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Marketing Status
DEA Schedule
Schedule II (Controlled)
Application #
NDA206627
Marketing Start
01/15/2015

Recall History

No Recall History

Side Effects Reported to FDA

FDA FAERS database · These are reported events, not confirmed side effects

death11,932 reports
drug dependence10,345 reports
overdose9,653 reports
toxicity to various agents9,499 reports
pain7,309 reports
emotional distress6,714 reports
drug withdrawal syndrome5,571 reports
drug abuse1,760 reports
drug withdrawal syndrome neonatal1,289 reports
nausea1,057 reports

Frequently Asked Questions

What is Hysingla ER used for?

Hysingla ER contains hydrocodone bitartrate. It is a tablet, extended release taken oral. Consult your doctor for specific uses.

Is Hysingla ER a controlled substance?

Yes, Hysingla ER is classified as CII under the DEA Controlled Substances Act.

What is the generic name for Hysingla ER?

The generic name for Hysingla ER is hydrocodone bitartrate. There are 12 other brand versions of hydrocodone bitartrate.

What is the NDC code for Hysingla ER 40 mg/1?

The NDC (National Drug Code) for Hysingla ER 40 mg/1 is 59011-273, listed by Knoa Pharma LLC.

Product NDC

59011-273

Package NDC

59011-273-60

Other Hydrocodone Brands

See all →

Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.

Data from openFDA · Public domain (CC0 1.0)